Shuttle Pharmaceuticals Holdings (SHPH) Cash from Investing Activities (2023 - 2026)

Shuttle Pharmaceuticals Holdings' Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$36000.0 for Q1 2026.

• On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to -$36000.0 in Q1 2026; TTM through Mar 2026 was $2.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$3.1 million, down 204.83% from the prior year.
• Cash from Investing Activities declined to -$36000.0 in Q1 2026 per SHPH's latest filing, from $1.7 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $1.7 million in Q3 2024 and bottomed at -$3.0 million in Q1 2023.
• The 3-year median for Cash from Investing Activities is $74920.5 (2023), against an average of $6255.2.
• Biggest YoY gain for Cash from Investing Activities was 6506.87% in 2024; the steepest drop was 103.43% in 2024.
• Year by year, Cash from Investing Activities stood at $87037.0 in 2023, then soared by 1803.21% to $1.7 million in 2024, then slumped by 102.17% to -$36000.0 in 2026.
• Per Business Quant, the three latest SHPH Cash from Investing Activities figures stand at -$36000.0 (Q1 2026), $1.7 million (Q3 2024), and $1.2 million (Q2 2024).